Hospitals now know how some health AI tools were developed. Will that change anything?
A new federal transparency rule requires some developers to disclose details about how their health AI tools were developed and tested.
Related Articles
Miles to Go and Nowhere to Sleep | NEJM
With no grandmaster moving the chess pieces of U.S. health care, weighing population density and disease distribution, rural health relies on urban centers — and…
Journal of the American College of Cardiology
Led by Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, JACC is the flagship publication of the family of peer-reviewed journals published by the American College of…
Allogeneic Stem Cell Donation
This JAMA Insights discusses allogenic stem cell donation, including the donation process and the effects of stem cell donation on donors.
Gender-affirming care drugs seldom used by kids: study
Less than 0.1% of U.S. adolescents received drugs for gender-affirming care between 2018 and 2022, according to a study published Monday.
G6PD deficiency triggers dopamine loss and the initiation of Parkinson’s disease pathogenesis
Stykel et al. show that G6PD missense mutations increase the risk of PD diagnosis and that α-syn accumulation leads to G6PD dysfunction and deposition into Lewy…
Metastatic Prostatic Adenocarcinoma With Paneth Cell–Like Neuroendocrine Differentiation
A patient in his late 60s with a prior history of widely metastatic prostatic adenocarcinoma was treated with androgen deprivation therapy and docetaxel chemotherapy. On…
Outset Medical announces $169M financing
Outset Medical (Nasdaq: OM) announced today that it entered into a definitive securities purchase agreement worth proceeds of $168.8 million.
Trends of acute respiratory infection, including human metapneumovirus, in the Northern Hemisphere
In many countries of the Northern Hemisphere, trends in acute respiratory infections increase at this time of year. These increases are typically caused by seasonal…
